Penumbra
PEN
#1688
Rank
A$18.29 B
Marketcap
A$464.05
Share price
0.37%
Change (1 day)
11.46%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

P/S ratio for Penumbra (PEN)

P/S ratio as of November 2026 (TTM): 8.36

According to Penumbra's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.22. At the end of 2023 the company had a P/S ratio of 9.17.

P/S ratio history for Penumbra from 2015 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20239.17-8.04%
20229.97-30.54%
202114.426.63%
202011.37.95%
201910.511.05%
20189.46-1.15%
20179.5724.8%
20167.67-11.31%
20158.65

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Merit Medical
MMSI
3.31-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Inari Medical
NARI
8.15-2.49%๐Ÿ‡บ๐Ÿ‡ธ USA